GDF-15 and Early Outcomes After LVAD Implantation
Recruiting · NCT07497308 · Observational (researchers observe without assigning treatment) · Lead sponsor: Akdeniz University
View the official record on ClinicalTrials.gov →What this trial is about
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adults aged 18 years and older
- Patients with advanced heart failure undergoing LVAD implantation
- Availability of preoperative GDF-15 measurement
- Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulations -
Exclusion criteria
- Age under 18 years
- Active infection
- Active malignancy
- Severe hepatic failure
- Missing study data
- Refusal to participate
Where it is running
1 location listed.
- Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation - Antalya, Please Select:, Turkey (Türkiye)